{"id":"https://genegraph.clinicalgenome.org/r/82a4bc15-1cea-43a2-baaa-6314886430b3v1.0","type":"EvidenceStrengthAssertion","dc:description":"*FGFR3* was first reported in relation to AD thanatophoric dysplasia in 1995 (Tavormina et al., PMID: 7773297). Thanatophoric dysplasia is a severe skeletal disorder characterized by extremely short limbs and redundant skin on the arms and legs. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities (thanatophoric dysplasia, type I, MIM:187600 and thanatophoric dysplasia, type II, MIM:187601) have been lumped into one disease entity, thanatophoric dysplasia. The split curations for SADDAN, CATSHL, hypochondroplasia, and achondroplasia have been curated separately. \n\n3 missense, 3 stop-loss, and one indel variants that have been reported in 19 probands in 5 publications (PMIDs: 7773297, 7647778, 19752524, 29458880, 27028100) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of disease is reported to be gain of function. This gene-disease association is also supported by experimental evidence including mouse models and functional assays in a cell line and patient cells (PMIDs: 10861287, 9069288, 9438390). In summary, there is definitive evidence supporting the relationship between *FGFR3* and AD thanatophoric dysplasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date January 13th, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/82a4bc15-1cea-43a2-baaa-6314886430b3","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2025-06-02T20:38:28.470Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2022-01-13T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30d3fc79-028a-44a6-bcb6-a8dc92a7f2e1","type":"EvidenceLine","dc:description":"Radiographs providing phenotypic specificity in this case.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30d3fc79-028a-44a6-bcb6-a8dc92a7f2e1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional study in zebrafish showing overexpression of FGFR3 and overactivation of downstream signalling.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/30d3fc79-028a-44a6-bcb6-a8dc92a7f2e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27028100","allele":{"id":"https://genegraph.clinicalgenome.org/r/c901de8b-a35a-413a-ac0d-de53cf0e9bba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.742_743insTGT (p.Arg248delinsLeuCys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2541708611"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/76c590b1-1d4d-4838-a012-67d08d87e66d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76c590b1-1d4d-4838-a012-67d08d87e66d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.1948A>G (p.Lys650Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA126376"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e2ccb855-92ef-4b47-a593-c227630ee6cf","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2ccb855-92ef-4b47-a593-c227630ee6cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.742C>T (p.Arg248Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA126378"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b2914af1-acfe-42bd-b658-ae1d666bd179","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2914af1-acfe-42bd-b658-ae1d666bd179_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7647778","allele":{"id":"https://genegraph.clinicalgenome.org/r/665fef35-a4d8-4f40-b965-844c9c97d55b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.2419T>A (p.Ter807Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341404"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d1941eec-ca4d-4d64-84bf-d0d4dc10bb9f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1941eec-ca4d-4d64-84bf-d0d4dc10bb9f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29458880","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/92a50fc6-c9c4-40a9-83de-2bf9605436d0","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92a50fc6-c9c4-40a9-83de-2bf9605436d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0c3b592c-8d14-4c06-b005-b7fde9c1ef2e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c3b592c-8d14-4c06-b005-b7fde9c1ef2e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/55396688-8c87-4619-93be-64b9ef20b647","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55396688-8c87-4619-93be-64b9ef20b647_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45eaa8ec-2701-438a-9edf-53e064ddfdfb","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45eaa8ec-2701-438a-9edf-53e064ddfdfb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/04561627-e382-4ff0-9eea-e5156acc21c7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04561627-e382-4ff0-9eea-e5156acc21c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8152f5e9-86cd-48f1-ac8d-21d67b3add68","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8152f5e9-86cd-48f1-ac8d-21d67b3add68_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/365201ed-f683-4a85-9ad6-c11f34e879c3","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/365201ed-f683-4a85-9ad6-c11f34e879c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7647778","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7533bf5-ffc2-4dd3-8a21-c80faeb44b6a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.2421A>T (p.Ter807Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341407"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1362bfe0-e39d-46f4-85cf-35be50202aea","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1362bfe0-e39d-46f4-85cf-35be50202aea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/08a35ad8-3738-4499-a9ce-471241e14338","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08a35ad8-3738-4499-a9ce-471241e14338_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7647778","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8a6cfb4-6411-4707-909d-17fcab747862","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.2419T>G (p.Ter807Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341401"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/746ed374-ac94-4006-bf46-a7415c68646b","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/746ed374-ac94-4006-bf46-a7415c68646b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c221529-eba5-4c64-a7cb-8e579017846a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000142.5(FGFR3):c.1111A>T (p.Ser371Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341399"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/44464f34-918b-4b41-b6a6-beb9c8ecdf87","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44464f34-918b-4b41-b6a6-beb9c8ecdf87_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5560b69d-1347-4979-bbb3-8044b1f1fe76","type":"EvidenceLine","dc:description":"These variants are highly specific to TD1, and are highly causative, and for this reason are scored at a higher level.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5560b69d-1347-4979-bbb3-8044b1f1fe76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0496dc3-a8d8-4ead-8862-6408c9cca3db"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/81eff71e-8fa7-4e36-ae6b-5a780d8fff73","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81eff71e-8fa7-4e36-ae6b-5a780d8fff73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f4245e27-0b9b-4e8e-9b3c-13522c78be23","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4245e27-0b9b-4e8e-9b3c-13522c78be23_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7773297","allele":{"id":"https://genegraph.clinicalgenome.org/r/789d056d-209e-424e-99a7-bb2b074fd902"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48071c26-9192-4f20-b374-07a08abf2f17","type":"EvidenceLine","dc:description":"Additional studies using the same mouse line were used to increase score (PMIDs: 12966031, 19192266, 25432534).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8faf78b0-7282-48e4-8630-96da6b2f8fd6","type":"Finding","dc:description":"GOF mechanism of disease is recapitulated, and severe phenotypes are shown in mouse model, similar to the neonatal lethal skeletal phenotypes.\nThis same mouse model was used in follow up studies to further define the phenotype and show its strong recapitulation of human TDII patients. Lin et al. 2003 (PMID: 12966031) used this mouse line crossed with CNS-specific Nestin-cre mice, and separately with cartilage specific Col2a1-Cre mice to show that the CNS phenotypes in human patients are directly caused by impaired FGFR3 in the brain, not secondary to the skeletal findings. Thomson et al. 2009 PMID: 19192266) showed that this mouse line with constitutively active FGFR3 in forebrain have markedly larger caudolateral cortex and greater cortical thickness at early postnatal stage. Zhou et al. 2015 (PMID: 25432534) used this mouse model with the variant expressed specifically in prehypertrophic chondrocytes, showing suppressed hypertrophic differentiation, inducing a differentiation block independent of any changes in proliferation, which coincides with persistent expression of SOX9, the master regulator of chondrogenesis; SOX9 haploinsufficiency allowed chondrocyte differentiation to proceed normally and significantly improved endochondral bone growth.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10861287","rdfs:label":"Iwata mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/6c00b5e7-5685-4f03-b9ac-1601b62e57c5_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ca70d83-bc74-4a57-9aac-c311cf5c5665","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ff503f2-6fe8-4682-84d5-a3ffa2c6381c","type":"FunctionalAlteration","dc:description":"Increase Stat1 and p21WAFI/CIPI were found in a TDII fetus. This study suggests that FGFR3 uses Stat1 and p21WAFI/CIPI as a mediator of growth impairment in bone development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9069288","rdfs:label":"Su patient cell study"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9d13f2c8-b620-4708-a083-03c343f5b452","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72b17e0d-a0d1-4105-bbbb-4353210d0f8f","type":"FunctionalAlteration","dc:description":"K650E variant FGFR3 over-activates and translocates Stat1 to the nucleus, increasing induction of cell cycle inhibitor p21WAFI/CIPI, and causes growth arrest of the cell.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9069288","rdfs:label":"Su functional alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/790dbab7-cac3-40bc-9ebf-a95110df6ad4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e974828-3c8d-4070-bf8a-512615ceed40","type":"FunctionalAlteration","dc:description":"R248C and S249C showed approximately 4-fold increase in luciferase activity compared to wild-type. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9438390","rdfs:label":"d'Avis Assay 1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea0eb45a-24b0-4f5e-9810-6f6c9045c972","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06bb5d0d-47b7-43f7-a1d5-b88ae6f7b2bd","type":"FunctionalAlteration","dc:description":"Control variant R248A showing that the Cys substitution is responsible for activation. GOF mechanism is shown, resulting in enhanced signaling due to constitutive activation of the receptor. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9438390","rdfs:label":"d'Avis Assay 2"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":10533,"specifiedBy":"GeneValidityCriteria8","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/oSyEr_wDg4Y","type":"GeneValidityProposition","disease":"obo:MONDO_0017042","gene":"hgnc:3690","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6c00b5e7-5685-4f03-b9ac-1601b62e57c5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}